Literature DB >> 15990919

Direct tumor damage mechanisms of photodynamic therapy.

Dominika Nowis1, Marcin Makowski, Tomasz Stokłosa, Magdalena Legat, Tadeusz Issat, Jakub Gołab.   

Abstract

Photodynamic therapy (PDT) is a clinically approved and rapidly developing cancer treatment regimen. It is a minimally invasive two-stage procedure that requires administration of a photosensitizing agent followed by illumination of the tumor with visible light usually generated by laser sources. A third component of PDT is molecular oxygen which is required for the most effective antitumor effects. In the presence of the latter, light of an appropriate wavelength excites the photosensitizer thereby producing cytotoxic intermediates that damage cellular structures. PDT has been approved in many countries for the treatment of lung, esophageal, bladder, skin and head and neck cancers. The antitumor effects of this treatment result from the combination of direct tumor cell photodamage, destruction of tumor vasculature and activation of an immune response. The mechanisms of the direct photodamage of tumor cells, the signaling pathways that lead to apoptosis or survival of sublethaly damaged cells, and potential novel strategies of improving the antitumor efficacy of PDT are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15990919

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  50 in total

1.  Effect of a newly synthesized Zn sulfophthalocyanine derivative on cell morphology, viability, proliferation, and cytotoxicity in a human lung cancer cell line (A549).

Authors:  Sello Lebohang Manoto; Heidi Abrahamse
Journal:  Lasers Med Sci       Date:  2011-01-29       Impact factor: 3.161

2.  Inhibition of breast cancer cell proliferation by a newly developed photosensitizer chrolophyll derivative CPD4.

Authors:  Zhu Qiao; Junye Wang; Huili Wang; Xiaowei Liu; Ruidong Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

3.  Aptamer-based multifunctional ligand-modified UCNPs for targeted PDT and bioimaging.

Authors:  Weijia Hou; Yuan Liu; Ying Jiang; Yuan Wu; Cheng Cui; Yanyue Wang; Liqin Zhang; I-Ting Teng; Weihong Tan
Journal:  Nanoscale       Date:  2018-06-14       Impact factor: 7.790

4.  Photodynamic therapy-induced angiogenic signaling: consequences and solutions to improve therapeutic response.

Authors:  Shannon M Gallagher-Colombo; Amanda L Maas; Min Yuan; Theresa M Busch
Journal:  Isr J Chem       Date:  2012-09-01       Impact factor: 3.333

5.  T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?

Authors:  Florian Anzengruber; Pinar Avci; Lucas Freitas de Freitas; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2015-06-11       Impact factor: 3.982

6.  Redox-sensitive cross-linking enhances albumin nanoparticle function as delivery system for photodynamic cancer therapy.

Authors:  Anna M Molina; Moraima Morales-Cruz; Marimar Benítez; Kiara Berríos; Cindy M Figueroa; Kai Griebenow
Journal:  J Nanomed Nanotechnol       Date:  2015-05-22

7.  5-Aza-2'-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy.

Authors:  Malgorzata Wachowska; Magdalena Gabrysiak; Angelika Muchowicz; Weronika Bednarek; Joanna Barankiewicz; Tomasz Rygiel; Louis Boon; Pawel Mroz; Michael R Hamblin; Jakub Golab
Journal:  Eur J Cancer       Date:  2014-02-18       Impact factor: 9.162

8.  Low concentrations of a non-hydrolysable tetra-S-glycosylated porphyrin and low light induces apoptosis in human breast cancer cells via stress of the endoplasmic reticulum.

Authors:  Sebastian Thompson; Xin Chen; Li Hui; Alfredo Toschi; David A Foster; Charles Michael Drain
Journal:  Photochem Photobiol Sci       Date:  2008-08-18       Impact factor: 3.982

9.  Photodynamic antimicrobial activity of new porphyrin derivatives against methicillin resistant Staphylococcus aureus.

Authors:  Hüseyin Taslı; Ayse Akbıyık; Nermin Topaloğlu; Vildan Alptüzün; Sülünay Parlar
Journal:  J Microbiol       Date:  2018-10-24       Impact factor: 3.422

10.  TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy.

Authors:  S Y Lee; S K Luk; C P Chuang; S P Yip; S S T To; Y M B Yung
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.